Omeros (Call) (OMER) Holder Cormorant Asset Management Has Boosted Position by $950,000; As Tower Intl (TOWR) Share Price Declined, Holder Towle & Co Has Trimmed by $2.04 Million Its Position

May 14, 2018 - By Clifton Ray

Omeros Corporation (NASDAQ:OMER) Logo

Towle & Co decreased its stake in Tower Intl Inc (TOWR) by 6.29% based on its latest 2017Q4 regulatory filing with the SEC. Towle & Co sold 68,050 shares as the company’s stock declined 15.80% with the market. The institutional investor held 1.01 million shares of the capital goods company at the end of 2017Q4, valued at $30.98M, down from 1.08 million at the end of the previous reported quarter. Towle & Co who had been investing in Tower Intl Inc for a number of months, seems to be less bullish one the $576.66 million market cap company. The stock increased 1.08% or $0.3 during the last trading session, reaching $28. About 21,378 shares traded. Tower International, Inc. (NYSE:TOWR) has risen 1.52% since May 14, 2017 and is uptrending. It has underperformed by 10.03% the S&P500.

Cormorant Asset Management Llc increased its stake in Omeros Corp (Call) (OMER) by 2.94% based on its latest 2017Q4 regulatory filing with the SEC. Cormorant Asset Management Llc bought 50,000 shares as the company’s stock declined 39.13% with the market. The hedge fund held 1.75 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $34.00 million, up from 1.70M at the end of the previous reported quarter. Cormorant Asset Management Llc who had been investing in Omeros Corp (Call) for a number of months, seems to be bullish on the $1.06B market cap company. The stock increased 9.85% or $1.96 during the last trading session, reaching $21.85. About 1.10M shares traded. Omeros Corporation (NASDAQ:OMER) has declined 3.39% since May 14, 2017 and is downtrending. It has underperformed by 14.94% the S&P500.

Towle & Co, which manages about $544.94M and $1.01B US Long portfolio, upped its stake in Fiat Chrysler Automobiles by 49,150 shares to 3.15M shares, valued at $56.12M in 2017Q4, according to the filing. It also increased its holding in Sportsmans Warehouse Holdings (NASDAQ:SPWH) by 1.39M shares in the quarter, for a total of 3.87 million shares, and has risen its stake in Goodyear Tire & Rubber Co (NASDAQ:GT).

Investors sentiment increased to 1.42 in 2017 Q4. Its up 0.24, from 1.18 in 2017Q3. It improved, as 10 investors sold TOWR shares while 45 reduced holdings. 31 funds opened positions while 47 raised stakes. 18.27 million shares or 0.28% more from 18.22 million shares in 2017Q3 were reported. Prudential Public Limited Com holds 652,000 shares or 0.06% of its portfolio. Meeder Asset Mngmt owns 0% invested in Tower International, Inc. (NYSE:TOWR) for 1,663 shares. Bogle Mngmt Limited Partnership De has invested 0.08% of its portfolio in Tower International, Inc. (NYSE:TOWR). Panagora Asset Inc invested 0% of its portfolio in Tower International, Inc. (NYSE:TOWR). Us Bank De invested in 122 shares or 0% of the stock. Dimensional Fund Advsrs LP stated it has 1.22 million shares or 0.02% of all its holdings. Towle & stated it has 3.06% in Tower International, Inc. (NYSE:TOWR). 10,226 are owned by Bowling Port Mgmt. Matarin Cap Mngmt Limited reported 135,704 shares. 10,287 are held by Aperio Ltd Co. Menta Capital Lc invested in 0.16% or 27,102 shares. Ubs Asset Management Americas holds 0% or 7,100 shares in its portfolio. Texas-based Hodges Cap has invested 0.07% in Tower International, Inc. (NYSE:TOWR). National Bank Of America De reported 0% in Tower International, Inc. (NYSE:TOWR). The Washington-based Parametric Associates Lc has invested 0% in Tower International, Inc. (NYSE:TOWR).

Among 5 analysts covering Tower International Inc (NYSE:TOWR), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Tower International Inc had 10 analyst reports since October 20, 2015 according to SRatingsIntel. On Tuesday, August 9 the stock rating was initiated by Seaport Global with “Buy”. The firm has “Buy” rating by FBR Capital given on Friday, June 30. The stock of Tower International, Inc. (NYSE:TOWR) earned “Outperform” rating by Wells Fargo on Monday, March 21. The firm has “Neutral” rating by Citigroup given on Wednesday, February 15. JP Morgan reinitiated Tower International, Inc. (NYSE:TOWR) on Friday, April 29 with “Neutral” rating. The firm has “Buy” rating given on Wednesday, March 14 by FBR Capital. The firm has “Market Perform” rating by Wells Fargo given on Friday, April 29. The rating was maintained by FBR Capital on Tuesday, February 13 with “Buy”. JP Morgan maintained Tower International, Inc. (NYSE:TOWR) rating on Wednesday, February 14. JP Morgan has “Neutral” rating and $31 target.

More recent Tower International, Inc. (NYSE:TOWR) news were published by: Globenewswire.com which released: “New Research Coverage Highlights Erie Indemnity, Merit Medical, Destination Maternity, Perry Ellis International …” on May 03, 2018. Also Streetinsider.com published the news titled: “Tower Int’l (TOWR) Tops Q1 EPS by 1c, Beats on Revenues; Offers FY18 EPS Outlook Below Consensus” on May 03, 2018. Seekingalpha.com‘s news article titled: “Tower International’s (TOWR) CEO Jim Gouin on Q1 2018 Results – Earnings Call Transcript” with publication date: May 03, 2018 was also an interesting one.

More notable recent Omeros Corporation (NASDAQ:OMER) news were published by: Schaeffersresearch.com which released: “3 Biotech Stocks Surging Today” on May 11, 2018, also Benzinga.com with their article: “Benzinga’s Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy’s Revenue Miss, FDA Warns E-Liquid Makers Again” published on May 11, 2018, Seekingalpha.com published: “Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics” on May 13, 2018. More interesting news about Omeros Corporation (NASDAQ:OMER) were released by: Benzinga.com and their article: “50 Biggest Movers From Friday” published on May 14, 2018 as well as Seekingalpha.com‘s news article titled: “Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President’s Healthcare Plans” with publication date: May 14, 2018.

Cormorant Asset Management Llc, which manages about $841.40 million and $955.30 million US Long portfolio, decreased its stake in Protagonist Therapeutics Inc by 100,000 shares to 400,000 shares, valued at $8.32M in 2017Q4, according to the filing. It also reduced its holding in Reata Pharmaceuticals Inc by 188,574 shares in the quarter, leaving it with 200,000 shares, and cut its stake in Omeros Corp (NASDAQ:OMER).

Among 9 analysts covering Omeros (NASDAQ:OMER), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Omeros had 35 analyst reports since August 10, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, August 2 by Maxim Group. The firm has “Buy” rating by Maxim Group given on Thursday, March 22. WBB Securities maintained it with “Strong Buy” rating and $75 target in Tuesday, August 18 report. Cantor Fitzgerald initiated Omeros Corporation (NASDAQ:OMER) on Friday, June 3 with “Buy” rating. Wedbush downgraded the stock to “Neutral” rating in Friday, March 23 report. The firm has “Market Perform” rating by Cowen & Co given on Thursday, November 2. The stock of Omeros Corporation (NASDAQ:OMER) earned “Hold” rating by Cantor Fitzgerald on Tuesday, June 13. The rating was maintained by Maxim Group with “Buy” on Tuesday, June 13. The rating was maintained by Cantor Fitzgerald with “Hold” on Thursday, August 24. As per Friday, March 23, the company rating was maintained by H.C. Wainwright.

Since January 3, 2018, it had 0 insider buys, and 2 selling transactions for $1.36 million activity. Another trade for 1,020 shares valued at $22,899 was made by JACOBSEN MICHAEL A on Wednesday, January 3.

Omeros Corporation (NASDAQ:OMER) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>